National Health Investors (NHI) Revenue (2009 - 2026)

National Health Investors (NHI) has reported Revenue for 18 consecutive years, with $121.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Revenue rose 33.81% year-over-year to $121.3 million; the trailing twelve-month figure through Jun 2026 stood at $432.1 million (up 23.94% YoY), and the FY2025 full-year result was $375.6 million, up 12.07% from the prior year.
• Revenue improved to $121.3 million in Q2 2026 per NHI's latest filing, from $115.1 million in the prior quarter.
• Across five years, Revenue topped out at $121.3 million in Q2 2026 and bottomed at $59.9 million in Q2 2022.
• Historically, Revenue has averaged $85.8 million across 5 years, with a median of $82.7 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Revenue decreased 19.41% in 2022, then jumped 33.81% in 2026.
• Over 5 years, Revenue stood at $70.7 million in 2022, then grew by 12.45% to $79.5 million in 2023, then grew by 7.92% to $85.8 million in 2024, then climbed by 23.4% to $105.8 million in 2025, then increased by 14.64% to $121.3 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $121.3 million, $115.1 million, and $105.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.